Cello Health Limited
Cello Health Limited, headquartered in Great Britain, is a leading consultancy firm specialising in the life sciences and healthcare sectors. Founded in 2015, the company has rapidly established itself as a trusted partner for pharmaceutical and biotechnology companies, offering a range of services that include market access, medical communications, and strategic consulting. With a strong presence in key operational regions across Europe and North America, Cello Health is renowned for its innovative approach to addressing complex industry challenges. The firm’s unique blend of scientific expertise and commercial insight enables clients to navigate the evolving healthcare landscape effectively. Notable achievements include a robust portfolio of successful client engagements and a commitment to delivering tailored solutions that drive value. Cello Health Limited continues to solidify its market position as a go-to resource for organisations seeking to enhance their impact in the competitive life sciences arena.
DitchCarbon Score
How does Cello Health Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cello Health Limited's score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cello Health Limited's reported carbon emissions
In 2024, Cello Health Limited reported total carbon emissions of approximately 47640 kg CO2e for Scope 1 and about 322050 kg CO2e for Scope 2. This reflects a slight increase in emissions from 2023, where Scope 1 emissions were about 44870 kg CO2e and Scope 2 emissions were approximately 311380 kg CO2e. Cello Health Limited does not currently disclose any Scope 3 emissions data. Despite the increase in emissions, Cello Health Limited has not set specific reduction targets or initiatives as part of their climate commitments. The company operates as a current subsidiary of Cello Health Limited, and all emissions data is directly sourced from their reporting. The company’s emissions per rupee of turnover remain consistent, indicating a stable operational efficiency in relation to their carbon footprint. Cello Health Limited continues to monitor and report its emissions, contributing to transparency in its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 44,870 | 00,000 |
| Scope 2 | 311,380 | 000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cello Health Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
